News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Elan Corporation PLC Investor Raises Questions Over Drug Deal
August 12, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
New York, Aug 11 (Reuters) - An activist Elan Corp Plc (ELN.I) investor is raising new questions over a potentially serious conflict of interest involving the sale of an Elan pain drug for a bargain basement price.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
August 12, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity
August 7, 2025
·
2 min read
·
Tristan Manalac
China
Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive
August 6, 2025
·
7 min read
·
Leslie Zhen Liang
Brain Cancer
Glioblastoma Funding Rises as Nonprofits Drive Interest and Pharma Returns to the Table
August 4, 2025
·
6 min read
·
Ben Hargreaves
